Literature DB >> 10877494

Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group.

E R Cooper1, M Charurat, D N Burns, W Blattner, R Hoff.   

Abstract

Trends in the vertical transmission rate of HIV and evolving antiretroviral usage between 1990 and 1998 within the Women and Infants Transmission Study were evaluated. A decline in mother-infant transmission was temporally associated with advances in therapy, especially when regimens including a protease inhibitor were included in the analysis.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10877494     DOI： 10.1097/00126334-200005010-00007

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


  12 in total

1.  Where is the M in MTCT? The broader issues in mother-to-child transmission of HIV.

Authors:  A Rosenfield; E Figdor
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

2.  Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013.

Authors:  Allan W Taylor; Steven R Nesheim; Xinjian Zhang; Ruiguang Song; Lauren F FitzHarris; Margaret A Lampe; Paul J Weidle; Patricia Sweeney
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

Review 3.  Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Authors:  Louise Kuhn; Ingrid Peterson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Authors:  Nila Bhana; Douglas Ormrod; Caroline M Perry; David P Figgitt
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy.

Authors:  Adriana Weinberg; Jeri E F Harwood; Elizabeth J McFarland; Jennifer Pappas; Jill Davies; Kay Kinzie; Emily Barr; Suzanne Paul; Carol Salbenblatt; Elizabeth Soda; Anna Vazquez; Charles A Peloquin; Myron J Levin
Journal:  Infect Dis Obstet Gynecol       Date:  2010-01-10

7.  Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Authors:  Grace M Aldrovandi; Clara Chu; William T Shearer; Daner Li; Jan Walter; Bruce Thompson; Kenneth McIntosh; Marc Foca; William A Meyer; Belinda F Ha; Kenneth C Rich; Jack Moye
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

8.  Perinatal Transmission of HIV: Recognition and Treatment Interventions.

Authors:  Jaime Deville; Yvonne Bryson
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

9.  Safety and tolerability of antiretrovirals during pregnancy.

Authors:  Adriana Weinberg; Jeri Forster-Harwood; Jill Davies; Elizabeth J McFarland; Jennifer Pappas; Kay Kinzie; Emily Barr; Suzanne Paul; Carol Salbenblatt; Elizabeth Soda; Anna Vazquez; Myron J Levin
Journal:  Infect Dis Obstet Gynecol       Date:  2011-04-11

10.  Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.

Authors:  K Boer; K England; M H Godfried; C Thorne
Journal:  HIV Med       Date:  2010-01-04       Impact factor: 3.180
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.